Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 101 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 156 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 140 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 208 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 202 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 227 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 156 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 165 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 0.0 | BCD100322A01 | 331 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 0.5 | BCD100322A03 | 160 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 1.0 | BCD100322A07 | 208 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 2.0 | BCD100322A11 | 208 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 4.0 | BCD100322A15 | 197 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 8.0 | BCD100322A19 | 232 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 12.0 | BCD100322A23 | 262 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | C | 24.0 | BCD100322A27 | 202 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 177 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 186 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 280 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 209 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 231 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 153 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 177 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 0.5 | BCD100322A04 | 157 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 1.0 | BCD100322A08 | 202 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 2.0 | BCD100322A12 | 229 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 4.0 | BCD100322A16 | 233 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 8.0 | BCD100322A20 | 231 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 12.0 | BCD100322A24 | 214 | pmol/sample |
| - | PE(40:6e)/PE(40:5p) | 25OH-Chol | 24.0 | BCD100322A28 | 215 | pmol/sample |